Cargando…
2528. Cefepime Induced Neurotoxicity in Patients With or Without a History of Seizures
BACKGROUND: Cefepime is a commonly utilized antimicrobial for the treatment of nosocomial infections and serves as a carbapenem sparing agent for the treatment of ampC inducible bacteria. Although generally tolerated, cefepime induced neurotoxicity (CIN) is a well-documented adverse effect that has...
Autores principales: | Baalbaki, Nadeem, Hoge, Christopher, Dar, Aleena, Mohsen, Mahinaz, Sackey, Joachim, Salim, Tanzila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679195/ http://dx.doi.org/10.1093/ofid/ofad500.2146 |
Ejemplares similares
-
2172. Assessment of Cefepime Neurotoxicity in the FDA Adverse Reporting System
por: Groff, Lindsey, et al.
Publicado: (2018) -
2528. Inflammation and Plasma Selenium and Chromium in Ugandan Children Living with HIV
por: Dirajlal-Fargo, Sahera, et al.
Publicado: (2019) -
Cefepime-Induced Neurotoxicity
por: Saini, Tanjot, et al.
Publicado: (2021) -
Assessing the association between cefepime percentage free trough level and neurotoxicity
por: Zia, Aleena, et al.
Publicado: (2022) -
628. Utilizing Cefepime Therapeutic Drug Monitoring for Patients at Risk of or Exhibiting Signs of Neurotoxicity
por: Au, Joanna, et al.
Publicado: (2022)